{"id":"https://openalex.org/W2108698263","doi":null,"title":"The role of ATP-sensitive potassium channel blockers in ischemia-reperfusion-induced renal injury versus their effects on cardiac ischemia reperfusion in rats.","display_name":"The role of ATP-sensitive potassium channel blockers in ischemia-reperfusion-induced renal injury versus their effects on cardiac ischemia reperfusion in rats.","publication_year":2009,"publication_date":"2009-03-01","ids":{"openalex":"https://openalex.org/W2108698263","mag":"2108698263","pmid":"https://pubmed.ncbi.nlm.nih.gov/19499842"},"language":"en","primary_location":{"id":"pmid:19499842","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19499842","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European review for medical and pharmacological sciences","raw_type":"Comparative Study"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101941282","display_name":"Mona Kamal Tawfik","orcid":"https://orcid.org/0000-0003-1580-9817","observed_orcids":["https://orcid.org/0000-0003-1580-9817"]},"institutions":[{"id":"https://openalex.org/I114794399","display_name":"Suez Canal University","ror":"https://ror.org/02m82p074","country_code":"EG","type":"education","lineage":["https://openalex.org/I114794399"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"Mona K Tawfik","raw_affiliation_strings":["Department of Pharmacology, Faculty of Medicine, Suez Canal University, Ismailia, Egypt. dmon_kamal@yahoo.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Faculty of Medicine, Suez Canal University, Ismailia, Egypt. dmon_kamal@yahoo.com","institution_ids":["https://openalex.org/I114794399"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023571726","display_name":"Dina Mohamed Abo\u2013Elmatty","orcid":"https://orcid.org/0000-0002-6074-2714","observed_orcids":["https://orcid.org/0000-0002-6074-2714"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dina M Abo-Elmatty","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5101151152","display_name":"Amal A.M. Ahmed","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amal A M Ahmed","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.423,"has_fulltext":false,"cited_by_count":8,"citation_normalized_percentile":{"value":0.67842055,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"13","issue":"2","first_page":"81","last_page":"93"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11057","display_name":"Cardiac Ischemia and Reperfusion","score":0.5508000254631042,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11057","display_name":"Cardiac Ischemia and Reperfusion","score":0.5508000254631042,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10684","display_name":"Acute Kidney Injury Research","score":0.4399000108242035,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13796","display_name":"Neuroprotection in Cerebral Ischemia","score":0.0017999999690800905,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/atp-sensitive-potassium-channels","display_name":"ATP-sensitive potassium channels","score":0.871999979019165},{"id":"https://openalex.org/keywords/glibenclamide","display_name":"glibenclamide","score":0.8109999895095825},{"id":"https://openalex.org/keywords/glimepiride","display_name":"glimepiride","score":1.0},{"id":"https://openalex.org/keywords/diazoxide","display_name":"diazoxide","score":0.8769999742507935},{"id":"https://openalex.org/keywords/ischemia-reperfusion-injury","display_name":"ischemia-reperfusion injury","score":0.9229999780654907},{"id":"https://openalex.org/keywords/renal-ischemia-reperfusion","display_name":"renal ischemia-reperfusion","score":0.7910000085830688},{"id":"https://openalex.org/keywords/myocardial-ischemia-reperfusion-injury","display_name":"myocardial ischemia-reperfusion injury","score":0.8759999871253967},{"id":"https://openalex.org/keywords/ischemic-preconditioning","display_name":"ischemic preconditioning","score":0.8880000114440918},{"id":"https://openalex.org/keywords/neutrophil-infiltration","display_name":"neutrophil infiltration","score":0.8799999952316284},{"id":"https://openalex.org/keywords/superoxide-production","display_name":"superoxide production","score":0.7979999780654907},{"id":"https://openalex.org/keywords/myeloperoxidase","display_name":"myeloperoxidase","score":0.9369999766349792},{"id":"https://openalex.org/keywords/tnf-alpha","display_name":"TNF-\u03b1","score":0.9879999756813049},{"id":"https://openalex.org/keywords/arterial-pressure","display_name":"arterial pressure","score":0.515999972820282},{"id":"https://openalex.org/keywords/cardiac-side-effects","display_name":"cardiac side effects","score":0.5799999833106995}],"concepts":[{"id":"https://openalex.org/C2779768347","wikidata":"https://www.wikidata.org/wiki/Q420626","display_name":"Glibenclamide","level":3,"score":0.9114874601364136},{"id":"https://openalex.org/C2776307423","wikidata":"https://www.wikidata.org/wiki/Q425027","display_name":"Glimepiride","level":4,"score":0.8498655557632446},{"id":"https://openalex.org/C2779872217","wikidata":"https://www.wikidata.org/wiki/Q420009","display_name":"Diazoxide","level":3,"score":0.8406280279159546},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7385073900222778},{"id":"https://openalex.org/C83743174","wikidata":"https://www.wikidata.org/wiki/Q423778","display_name":"Potassium channel","level":2,"score":0.6003256440162659},{"id":"https://openalex.org/C541997718","wikidata":"https://www.wikidata.org/wiki/Q188151","display_name":"Ischemia","level":2,"score":0.5575919151306152},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5257371664047241},{"id":"https://openalex.org/C2780091579","wikidata":"https://www.wikidata.org/wiki/Q9377","display_name":"Kidney","level":2,"score":0.436740517616272},{"id":"https://openalex.org/C2780721119","wikidata":"https://www.wikidata.org/wiki/Q7312492","display_name":"Renal ischemia","level":4,"score":0.4134114682674408},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.4111829102039337},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4105144143104553},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3902282416820526},{"id":"https://openalex.org/C2780114680","wikidata":"https://www.wikidata.org/wiki/Q1413991","display_name":"Reperfusion injury","level":3,"score":0.371423602104187},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.34564581513404846},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.16125574707984924},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.13858604431152344},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.06827476620674133}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001794","descriptor_name":"Blood Pressure","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003981","descriptor_name":"Diazoxide","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004562","descriptor_name":"Electrocardiography","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005905","descriptor_name":"Glyburide","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005905","descriptor_name":"Glyburide","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D007668","descriptor_name":"Kidney","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D007668","descriptor_name":"Kidney","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008168","descriptor_name":"Lung","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008168","descriptor_name":"Lung","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D013453","descriptor_name":"Sulfonylurea Compounds","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D013453","descriptor_name":"Sulfonylurea Compounds","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D013481","descriptor_name":"Superoxides","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014665","descriptor_name":"Vasodilator Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D015427","descriptor_name":"Reperfusion Injury","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D015427","descriptor_name":"Reperfusion Injury","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D015428","descriptor_name":"Myocardial Reperfusion Injury","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D019157","descriptor_name":"Ischemic Preconditioning, Myocardial","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D026902","descriptor_name":"Potassium Channel Blockers","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D026902","descriptor_name":"Potassium Channel Blockers","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054086","descriptor_name":"KATP Channels","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:19499842","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19499842","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European review for medical and pharmacological sciences","raw_type":"Comparative Study"},{"id":"mag:2108698263","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19499842","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":34,"referenced_works":["https://openalex.org/W1506421429","https://openalex.org/W1555144527","https://openalex.org/W1821855366","https://openalex.org/W1978705754","https://openalex.org/W1998559156","https://openalex.org/W2006724068","https://openalex.org/W2008066651","https://openalex.org/W2021114973","https://openalex.org/W2045871570","https://openalex.org/W2062709088","https://openalex.org/W2071829959","https://openalex.org/W2072283301","https://openalex.org/W2074042972","https://openalex.org/W2086239707","https://openalex.org/W2090591840","https://openalex.org/W2092951804","https://openalex.org/W2097082675","https://openalex.org/W2102064219","https://openalex.org/W2103469756","https://openalex.org/W2106225712","https://openalex.org/W2109876779","https://openalex.org/W2117100705","https://openalex.org/W2117966002","https://openalex.org/W2134320316","https://openalex.org/W2135871453","https://openalex.org/W2138166276","https://openalex.org/W2139791477","https://openalex.org/W2144000554","https://openalex.org/W2162891101","https://openalex.org/W2163072437","https://openalex.org/W2164472877","https://openalex.org/W2228240169","https://openalex.org/W2339154093","https://openalex.org/W2413484480"],"related_works":["https://openalex.org/W2086239707","https://openalex.org/W2172901384","https://openalex.org/W2143027529","https://openalex.org/W2367955413","https://openalex.org/W1567331800","https://openalex.org/W1980642677","https://openalex.org/W2153475498","https://openalex.org/W2393069872","https://openalex.org/W2062392691","https://openalex.org/W2364800688"],"abstract_inverted_index":{"In":[0,199],"renal":[1,20,42,73,84,228],"ischemia":[2,80],"reperfusion":[3,81,175],"(V/R),":[4],"opening":[5],"of":[6,16,31,176,203,210,227],"adenosine-triphosphate":[7],"(ATP)-sensitive":[8],"potassium":[9,33],"(K(ATP))":[10],"channels":[11],"results":[12],"in":[13,18,44,90,110,114,133,155,167,184],"massive":[14],"influx":[15],"neutrophils":[17],"both":[19,115],"and":[21,37,54,75,98,117],"lung":[22],"tissues.":[23],"Our":[24],"study":[25],"was":[26],"focused":[27],"on":[28,39,51,55,123],"the":[29,111,152,177,185,195,201,207,213,232],"role":[30],"ATP-dependent":[32],"channel":[34],"modulators,":[35],"glimepiride":[36,139,148,216,221],"glibenclamide":[38,103,128,161,204],"I/R":[40,74,77,229],"induced":[41,82,129,163],"injury":[43,113],"rats.":[45],"Additionally":[46],"we":[47,71],"evaluated":[48],"their":[49],"effects":[50,209],"normal":[52],"heart":[53,58],"ischemic":[56,61,178],"reperfused":[57],"subjected":[59],"to":[60,138],"preconditioning":[62],"protection":[63],"afforded":[64],"by":[65,194],"diazoxide.":[66,198],"To":[67],"test":[68],"this":[69],"hypothesis,":[70],"used":[72],"cardiac":[76,234],"experiment.":[78],"Renal":[79],"marked":[83],"dysfunction":[85],"associated":[86],"with":[87,102,157,197,215,230],"significant":[88,108,131,165,182],"increase":[89],"arterial":[91],"pressure,":[92],"TNF-alpha":[93],"levels,":[94],"superoxide":[95,124],"anion":[96,125],"production,":[97],"myeloperoxidase":[99],"activity.":[100],"Treatment":[101],"or":[104],"glimepiride,":[105],"demonstrated":[106],"a":[107,130,164,181],"improvement":[109,132],"reperfusion-induced":[112],"kidney":[116],"lung.":[118],"Glimepiride":[119],"has":[120],"no":[121],"effect":[122],"production.":[126],"However":[127],"these":[134,168],"measurements":[135],"as":[136],"compared":[137],"group.":[140,159],"Before":[141],"coronary":[142,172],"artery":[143,173],"ligation,":[144,174],"neither":[145],"diazoxide":[146],"nor":[147],"pretreatment":[149,196,214],"influenced":[150],"significantly":[151,192,205],"electrocardiographic":[153,187],"parameters":[154],"comparison":[156],"control":[158],"Conversely,":[160],"supplementation":[162],"elevation":[166,183],"parameters.":[169,188],"After":[170],"left":[171],"hearts":[179],"caused":[180],"measured":[186],"These":[189],"elevations":[190],"were":[191],"ameliorated":[193],"conclusion,":[200],"administration":[202],"abolished":[206],"protective":[208],"diazoxide,":[211],"while":[212],"didn't":[217],"abolish":[218],"it.":[219],"So,":[220],"offers":[222],"some":[223],"promise":[224],"for":[225],"therapy":[226],"minimizing":[231],"undesirable":[233],"side":[235],"effects.":[236]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}